Back to search

The Use of Virtual Screening in ALK5 Kinase Inhibitor Discovery and Validation of Orally Active ALK5 Kinase Inhibitors in Oncology

Data up to Jan 2025

Published2008
Citations8
References37

Total Citations Per Year

Abstract

References (37)

Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus

2003 • 5,611 citations

Smad-dependent and Smad-independent pathways in TGF-β family signalling

2003 • 5,052 citations

Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer

2003 • 1,572 citations

Role of Transforming Growth Factor Beta in Human Cancer

2005 • 703 citations

Development of TGF-β signalling inhibitors for cancer therapy

2004 • 536 citations

Structural Interaction Fingerprint (SIFt): A Novel Method for Analyzing Three-Dimensional Protein−Ligand Binding Interactions

2003 • 529 citations

Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12

1999 • 433 citations

Structural basis of inhibitor selectivity in MAP kinases

1998 • 408 citations

SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma CellsIn vitroandIn vivo

2004 • 407 citations

Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution

1998 • 309 citations

The ALK‐5 inhibitor A‐83‐01 inhibits Smad signaling and epithelial‐to‐mesenchymal transition by transforming growth factor‐β

2005 • 306 citations

Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain

2003 • 231 citations

Overexpression of Transforming Growth Factor β1 in Head and Neck Epithelia Results in Inflammation, Angiogenesis, and Epithelial Hyperproliferation

2004 • 191 citations

Dual Role of Transforming Growth Factor β in Mammary Tumorigenesis and Metastatic Progression

2005 • 169 citations

Successful shape-Based virtual screening: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI)

2003 • 161 citations

Transforming Growth Factor-β

2005 • 152 citations

Activated type I TGFβ receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression

2005 • 137 citations

A Novel Small-Molecule Inhibitor of Transforming Growth Factor β Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth In vivo and Prevents Tumor Recurrence after Surgical Resection

2007 • 110 citations

Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.

1996 • 109 citations

Transforming Growth Factor β Receptor I Kinase Inhibitor Down-Regulates Cytokine Secretion and Multiple Myeloma Cell Growth in the Bone Marrow Microenvironment

2004 • 108 citations

Interaction Profiles of Protein Kinase−Inhibitor Complexes and Their Application to Virtual Screening

2004 • 95 citations

Overexpression of activin A in stage IV colorectal cancer

2001 • 95 citations

Mechanism of Poly(A) Polymerase: Structure of the Enzyme-MgATP-RNA Ternary Complex and Kinetic Analysis

2007 • 87 citations

TGF-β inhibitors for the treatment of cancer

2005 • 83 citations

Concomitant over-expression of activin/inhibin β subunits and their receptors in human pancreatic cancer

1998 • 61 citations

Inhibin Resistance Is Associated with Aggressive Tumorigenicity of Ovarian Cancer Cells

2005 • 60 citations

Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-β signaling in ErbB2/Neu-induced tumors from transgenic mice

2005 • 59 citations

Interference with TGF‐β1 and ‐β3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinoma

2002 • 53 citations

Inhibition of TGF-β modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinoma

2005 • 53 citations

Protein kinase inhibition: natural and synthetic variations on a theme

1997 • 52 citations

Transforming the TGFbeta pathway: convergence of distinct lead generation strategies on a novel kinase pharmacophore for TbetaRI (ALK5).

2004 • 40 citations

Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE)

2001 • 38 citations

Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma

2000 • 35 citations

Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation

1996 • 29 citations

Activated type I TGFbeta receptor (Alk5) kinase confers enhanced survival to mammary epithelial cells and accelerates mammary tumor progression

2005 • 8 citations

Knowledge = power

2003 • 5 citations

Different routes to the same answer

2003 • 3 citations

Cited By (0)

Loading...
The Use of Virtual Screening in ALK5 Kinase Inhibitor Discovery and Validation of Orally… (2008) – Humana Press eBooks | Metascience Observatory Explorer